Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

Valeant Pharmaceuticals was founded in 1960 and is headquartered in Aliso Viejo, California. Valeant Pharmaceuticals International is a multi-national specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. The Company focuses on the therapeutic areas of dermatology and neurology. Its products are sold through three segments: Specialty Pharmaceuticals, Branded Generics (Europe) and Branded Generics (Latin America). In January 2008, the Company sold its product rights to Three Rivers Pharmaceuticals, LLC. In June 2008, the Company sold its subsidiaries in Argentina and Uruguay. In September 2008, the Company sold its business operations located in Western and Eastern Europe, Middle East and Africa (the WEEMEA business) to Meda AB of Sweden. In October 2008, the Company completed a worldwide License and Collaboration Agreement with Glaxo Group Limited, a wholly owned subsidiary of GlaxoSmithKline plc. In May 2009, the Company acquired EMO-FARM Ltd., a privately held company located in Poland.

Contact Details

Office Address

Valeant Pharmaceuticals International
One Enterprise
Aliso Viejo, CA, USA 92656
Phone: (949) 461-6000
Fax: (949) 461-6009

Executives

Chairman & Chief Exec. Officer

Mr. J. Michael Pearson

Chief Financial Officer

Mr. Peter J. Blott

Business Reviews for Valeant Pharmaceuticals International

Related Companies